![Expert Q&A: Trends and Challenges in Lab Billing and Coding](https://www.g2intelligence.com/wp-content/uploads/2024/01/Feb24.LIA_.ExpertQA.AnnLambrix-iStock-1432903655-1100x800-1-1080x675.jpg)
Expert Q&A: Trends and Challenges in Lab Billing and Coding
Ann Lambrix, vice president of RCM Solutions at Lighthouse Lab Services, discusses key developments in lab billing and coding.
Ann Lambrix, vice president of RCM Solutions at Lighthouse Lab Services, discusses key developments in lab billing and coding.
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.